Latest news
Categories
News archive
CEO Comment Q1 2022
9 May, 2022
A NEW CHAPTER BEGINS On March 29, 2022, a new chapter in Nanologica’s history began – as listed on a regulated market. By listing the share on Nasdaq Stockholm Main Market, we get an increased exposure and a better opportunity to attract institutional and international owners. At the same time, we are now launching our products for preparative chromatography. The big event of the quarter was the change of lists to Nasdaq Stockholm Main Market,
Introducing NLAB Saga®- a new generation silica for preparative chromatography
9 May, 2022
We are officially launching NLAB Saga® – Nanologica’s silica for preparative chromatography! NLAB Saga was developed with a clear goal in mind – to increase the availability of better and cheaper peptide and oligonucleotide-based medicines to a larger number of patients across the world, for the betterment of mankind. NLAB Saga has been specifically developed to meet the strict requirements of industrial scale purification by chromatography. Due to its exceptional mechanical and chemical stability, NLAB
Kallelse till årsstämma i Nanologica AB (publ)
4 May, 2022
Aktieägarna i Nanologica AB (publ), org.nr 556664-5023 (”Bolaget”) kallas härmed till årsstämma torsdagen den 2 juni 2022, klockan 12.00, i The Parks lokaler på Magnus Ladulåsgatan 1, Stockholm. Rätt att delta vid stämman Aktieägare som önskar delta i årsstämman ska: dels vara registrerad i eget namn (inte förvaltarregistrerad) i den av Euroclear Sweden AB förda aktieboken tisdagen den 24 maj 2022, dels anmäla sitt deltagande så att anmälan är Bolaget tillhanda senast måndagen den 30
Nanologica’s Interim Report Jan-Mar 2022
29 April, 2022
PERIOD IN BRIEF FINANCIAL SUMMARY Net sales for the first quarter amounted to TSEK 270 (5,622) The operating result amounted to TSEK -15,592 (-6,768) Result after tax amounted to TSEK -15,915 (-7,845) Earnings per share before and after dilution were SEK -0.57 (-0.28) Cash and cash equivalents amounted to TSEK 3,969 (57,069) as per March 31, 2022 SIGNIFICANT EVENTS IN THE FIRST QUARTER In January, a credit facility of up to MSEK 50 was signed